Finite element analysis of patient-specific additive-manufactured implants.

Bone tumors, characterized by diverse locations and shapes, often necessitate surgical excision followed by custom implant placement to facilitate targeted bone reconstruction. Leveraging additive manufacturing, patient-specific implants can be precisely tailored with complex geometries and desired stiffness, enhancing their suitability for bone ingrowth. In this work, a finite element model is employed to assess patient-specific lattice implants in femur bones.

The association between mental health stigma and face emotion recognition in individuals at risk for psychosis.

Self-stigma has been associated with reduced accuracy of face emotion recognition in individuals at clinical high risk for psychosis (CHR). Stigma may also relate to slowing of performance during cognitive tasks for which a negative stereotype is relevant. This study aimed to investigate the association of mental illness stigma with face emotion recognition among CHR individuals.

Emotional and stigma-related experiences relative to being told one is at risk for psychosis.

Objective: Despite the appeal of early intervention in psychosis, there is concern that identifying youth as having high psychosis risk (PR) may trigger stigma. This study employed a pre-post design to measure change in PR participants' emotions about PR upon being told of their PR status and according to whether this was the first time receiving this information.

Methods: Participants (n = 54) identified as at PR via structured interview rated their emotions about PR before and after being told they were at PR.

Perceptions, Policy, and Partnerships: How Pharmacists Can Be Leaders in Reducing Overprescribing.

Medication overload - or harmful polypharmacy - is a widespread and growing public health issue, impacting millions of older Americans each year. Pharmacists are uniquely positioned to help deprescribe (collaboratively reduce inappropriate medication use), but also face significant obstacles to doing so. This paper explores three ways to involve pharmacists more in deprescribing to mitigate medication overload: Widen public perceptions of pharmacists' role in medication management, change policies that hinder pharmacist involvement in deprescribing, and encourage partnerships between stakeholders across disciplines.